TCI Wealth Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-90
Closed -$19.5K 2411
2023
Q1
$19.5K Hold
90
﹤0.01% 718
2022
Q4
$18.5K Sell
90
-14
-13% -$3.54K ﹤0.01% 733
2022
Q3
$29K Buy
104
+14
+16% +$3.56K ﹤0.01% 529
2022
Q2
$17K Hold
90
﹤0.01% 721
2022
Q1
$19K Sell
90
-63
-41% -$10.4K ﹤0.01% 730
2021
Q4
$27K Buy
153
+36
+31% +$7.1K ﹤0.01% 583
2021
Q3
$24K Buy
117
+27
+30% +$5.3K ﹤0.01% 621
2021
Q2
$17K Buy
90
+37
+70% +$6.05K ﹤0.01% 676
2021
Q1
$7K Buy
53
+43
+430% +$5.16K ﹤0.01% 1097
2020
Q4
$1K Sell
10
-13
-57% -$1.13K ﹤0.01% 1490
2020
Q3
$2K Hold
23
﹤0.01% 1212
2020
Q2
$1K Sell
23
-91
-80% -$3.75K ﹤0.01% 1397
2020
Q1
$4K Hold
114
﹤0.01% 807
2019
Q4
$5K Buy
114
+13
+13% +$480 ﹤0.01% 877
2019
Q3
$3K Buy
+101
New +$4.29K ﹤0.01% 1005

Other funds holding SWAV

TCI Wealth Advisors's SWAV Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2023, closing a stake of 90 shares — an estimated $19.5K sold.

TCI Wealth Advisors first reported a position in SWAV in Q3 2019 and held it in 15 quarters. The position peaked at $29K in Q3 2022. 460 funds tracked by Wall St. Rank hold SWAV as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 90 Shockwave Medical, Inc. Common Stock shares in Q2 2023, an estimated $19.5K.
  • TCI Wealth Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2019 and held it in 15 quarters.
  • TCI Wealth Advisors's Shockwave Medical, Inc. Common Stock position peaked at $29K in Q3 2022.
  • 460 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.